Pharmacokinetics of Tramadol and its Metabolites M1, M2 and M5 in Horses Following Intravenous, Immediate Release (Fasted/Fed) and Sustained Release Single Dose Administration

Journal of Equine Veterinary Science

Volumn 27, Issue 11, 2007, Pages 481-488

  Giorgi, Mario ^a   Soldani, Giulio ^a   Manera, Clementina ^a   Ferrarini, PierLuigi ^a   Sgorbini, Micaela ^a   Saccomanni, Giuseppe ^a  

^a V le delle Piagge ^*  (Italy)

Author keywords

Horse; Metabolism; Pharmacokinetic; Sustained release; Tramadol

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; CAVIA; EQUIDAE; MESOCRICETUS AURATUS; MUS; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 36248953167     PISSN: 07370806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jevs.2007.10.004     Document Type: Article

References (25)

1. Lee C.R., McTavish D., and Sorkin E.M. Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 46 (1993) 313-340
2. Collart L., Luthy C., Favario-Constantin C., and Dayer P. Duality of the analgesic effect of tramadol in humans. Schweiz Med Wochenschr 123 (1993) 2241-2243
3. Desmeules J.A., Piguet V., Collart L., and Dayer P. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol 41 (1996) 7-12
4. Ide S., Minami M., Ishihara K., Uhl G.R., Sora I., and Ikeda K. Mu opioid receptor-dependent and independent components in effects of tramadol. Neuropharmacology 51 (2006) 651-658
5. Tuncer S., Pirbudak L., Balat O., and Capar M. Adding ketoprofen to intravenous patient-controlled analgesia with tramadol after major gynecological cancer surgery: a double-blinded, randomized, placebo-controlled clinical trial. Eur J Gynaecol Oncol 24 (2003) 181-184
6. Close B.R. Tramadol: does it have a role in emergency medicine?. Emerg Med Australas 17 (2005) 73-83
7. Hoogewijs J., Diltoer M.W., Hubloue I., Spapen H.D., Camu F., Corne L., et al. A prospective, open, single blind, randomized study comparing four analgesics in the treatment of peripheral injury in the emergency department. Eur J Emerg Med 7 (2000) 119-123
8. Turturro M.A., Paris P.M., and Larkin G.L. Tramadol versus hydrocodone-acetaminophen in acute musculoskeletal pain: a randomized, double-blind clinical trial. Ann Emerg Med 32 (1998) 139-143
9. Wu W.N., McKown L.A., and Liao S. Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites. Xenobiotica 32 (2002) 411-425
10. Lintz W., Erlacin S., Frankus E., and Uragg H. Biotransformation of tramadol in man and animal. Arzneim Forsch Drug Res 31 (1981) 1932-1943
11. Subrahmanyam V., Renwick A.B., Young P.J., Price R.J., Tonelli A.P., and Lake B.G. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes. Drug Metab Dispos 29 (2001) 1146-1155
12. Raffa R.B., Friderichs E., Reimann W., Shank R.P., Codd E.E., and Vaught J.L. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 260 (1992) 275-285
13. Kogel B, Englberger W, Hennies HH, Friderichs E. Involvement of metabolites in the analgesic action of tramadol. Proceedings 9th World Congress of Pain; 1999:523.
14. Gillen C., Haurand M., Kobelt D.J., and Wnendt S. Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn Schmiedeberg Arch Pharmacol 362 (2000) 116-121
15. Garrido M.J., Valle M., Campanero M.A., Calvo R., and Troconiz I.F. Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats. J Pharmacol Exp Ther 295 (2000) 352-359
16. Garrido M.J., Sayar O., Segura C., Rapado J., Dios-Vieitez M.C., Renedo M.J., et al. Pharmacokinetic/pharmacodynamic modeling of the antinociceptive effects of (+)-tramadol in the rat: role of cytochrome P450 2D activity. J Pharmacol Exp Ther 305 (2003) 710-718
17. Gibaldi M., and Perrier D. Pharmacokinetics. 2nd ed. (1982), M. Dekker, New York
18. KuKanich B., and Papich M.G. Pharmacokinetics of tramadol and the metabolite O-desmethyltramadol in dogs. J Vet Pharmacol Ther 27 (2004) 239-246
19. Paar W.D., Poche S., Gerloff J., and Dengler H.J. Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol. Eur J Clin Pharmacol 53 (1997) 235-239
20. Scott L.J., and Perry C.M. Tramadol: a review of its use in perioperative pain. Drugs 60 (2000) 139-176
21. Nebbia C., Ceppa L., Dacasto M., Nachtmann C., and Carletti M. Oxidative monensin metabolism and cytochrome P450 3A content and functions in liver microsomes from horses, pigs, broiler chicks, cattle and rats. J Vet Pharmacol Ther 24 (2003) 399-403
22. Giorgi M., Saccomanni G., Daniello M.R., Manera C., Soldani G., Ferrarini P.L., et al. In vitro metabolism of tramadol in horses: preliminary data. J Vet Pharmacol Ther 26 (2006) 124
23. Wu W.N., McKown L.A., Gauthier A.D., Jones W.J., and Raffa R.B. Metabolism of the analgesic drug, tramadol hydrochloride, in rat and dog. Xenobiotica 31 (2001) 423-441
24. Rouini M.R., Ardakani Y.H., Soltani F., Aboul-Enein H.Y., and Foroumadi A. Development and validation of a rapid HPLC method for simultaneous determination of tramadol, and its two main metabolites in human plasma. J Chromatogr B 830 (2006) 207-211
25. Raber M., Schulz H.U., Schurer M., Bias-Imhoff U., and Momberger H. Pharmacokinetic properties of tramadol sustained release capsules. 2nd communication: investigation of relative bioavailability and food interaction. Arzneim Forsch Drug Res 49 (1999) 588-593